Douglas Fair
No Rating Available
(Learn About Our Rating System)

Douglas Fair, MD, MS, FAAP

Languages spoken: English

Clinical Locations

Primary Location

Primary Children's Hospital

100 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-662-2900
Get Directions

Dr. Fair received his medical degree from Albany Medical College, completed his Pediatric residency at UT Southwestern in Austin at Dell Children´s Hospital, and his Pediatric Hematology/ Oncology Fellowship here at the University of Utah. He also received additional training in Clinical Research through the Masters of Science in Clinical Investigation Program at the University of Utah. He has also received a Utah Certificate of Palliative Education (UCoPE).

Dr. Fair joined the University of Utah faculty in 2016 and is currently an Associate Professor of Pediatrics in the Division of Hematology/ Oncology.

Dr. Fair serves as the Director of the Primary Children’s Hospital Solid Tumor Program. He also is the Founder and Medical Director of the Childhood, Adolescent, and Young Adult (AYA) Cancer Survivorship Program at Primary Children’s Hospital. He serves as the Director of the Huntsman Cancer Institute AYA Program and as the co-Medical Director of the Huntsman Intermountain Adolescent and Young Adult Program (HIAYA). He is the Founder and co-Medical Director of the University of Utah, Primary Children’s Hospital, and Huntsman Cancer Institute’s Oncofertility Programs. He also co-Founded and served for over 5 years as the Associate Director of the Primary Children’s Hospital Supportive Oncology for Adolescents and Pediatrics Program (SOAP).

At the national level, Dr. Fair has served on numerous committees and steering committees. Some of these include serving on the steering committees for the Soft Tissue Sarcoma Group and Rare Tumor Group within the Children’s Oncology Group (COG). He also served as a member of the AYA Responsible Investigator (RI) Group within COG. He currently serves on many National Comprehensive Cancer Network (NCCN) AYA Guideline Committees, and has previously served on the NCCN Neuroblastoma Guideline Committee and the Wilm's Tumor Committee. He is also a leader in the Oncofertility Consortium. He also serves on advisory boards for numerous non-profit and philanthropic organizations benefiting pediatric and AYA cancer causes. Dr. Fair has also been active in advocating for gaps in insurance coverage for cancer patients, playing a lead role in changing policy at the insurance provider and legislative level.

Dr. Fair´s research interests include improving survival outcomes for children and AYAs diagnosed with solid tumors, specifically clinical trial development for sarcomas and rare tumors. He is also involved in research investigating improved outcomes and care for survivors of pediatric and AYA cancer. Another area of research is the gonadal and fertility function of cancer survivors, and the understanding of the gonadal toxic and gonadal protective agents in cancer therapy

Specialties

Board Certification

American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)
American Board of Pediatrics (Pediatrics)

Dr. Fair received his medical degree from Albany Medical College, completed his Pediatric residency at UT Southwestern in Austin at Dell Children´s Hospital, and his Pediatric Hematology/ Oncology Fellowship here at the University of Utah. He also received additional training in Clinical Research through the Masters of Science in Clinical Investigation Program at the University of Utah. He has also received a Utah Certificate of Palliative Education (UCoPE).

Dr. Fair joined the University of Utah faculty in 2016 and is currently an Associate Professor of Pediatrics in the Division of Hematology/ Oncology.

Dr. Fair serves as the Director of the Primary Children’s Hospital Solid Tumor Program. He also is the Founder and Medical Director of the Childhood, Adolescent, and Young Adult (AYA) Cancer Survivorship Program at Primary Children’s Hospital. He serves as the Director of the Huntsman Cancer Institute AYA Program and as the co-Medical Director of the Huntsman Intermountain Adolescent and Young Adult Program (HIAYA). He is the Founder and co-Medical Director of the University of Utah, Primary Children’s Hospital, and Huntsman Cancer Institute’s Oncofertility Programs. He also co-Founded and served for over 5 years as the Associate Director of the Primary Children’s Hospital Supportive Oncology for Adolescents and Pediatrics Program (SOAP).

At the national level, Dr. Fair has served on numerous committees and steering committees. Some of these include serving on the steering committees for the Soft Tissue Sarcoma Group and Rare Tumor Group within the Children’s Oncology Group (COG). He also served as a member of the AYA Responsible Investigator (RI) Group within COG. He currently serves on many National Comprehensive Cancer Network (NCCN) AYA Guideline Committees, and has previously served on the NCCN Neuroblastoma Guideline Committee and the Wilm's Tumor Committee. He is also a leader in the Oncofertility Consortium. He also serves on advisory boards for numerous non-profit and philanthropic organizations benefiting pediatric and AYA cancer causes. Dr. Fair has also been active in advocating for gaps in insurance coverage for cancer patients, playing a lead role in changing policy at the insurance provider and legislative level.

Dr. Fair´s research interests include improving survival outcomes for children and AYAs diagnosed with solid tumors, specifically clinical trial development for sarcomas and rare tumors. He is also involved in research investigating improved outcomes and care for survivors of pediatric and AYA cancer. Another area of research is the gonadal and fertility function of cancer survivors, and the understanding of the gonadal toxic and gonadal protective agents in cancer therapy

Board Certification and Academic Information

Academic Departments Pediatrics -Associate Professor (Clinical)
Academic Divisions Hematology/Oncology
Board Certification
American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)
American Board of Pediatrics (Pediatrics)

Education history

Undergraduate Biology/ Philosophy - Siena College B.A.
Professional Medical Medicine - Albany Medical College M.D.
Internship Pediatrics - University of Texas Southwestern ¿ Austin Intern
Residency Pediatrics - University of Texas Southwestern ¿ Austin Resident
Fellowship Pediatric Hematology/Oncology - University of Utah Fellow
Graduate Training Clinical Research - University of Utah M.S.C.I

Selected Publications

Journal Article

  1. Garg D, Johnstone EB, Fair DB, Carrell DT, Berga S, Letourneau J (2019). Oncofertility conundrum: discrepancy between anti-M'llerian hormone and mature oocyte yield in a peripubertal girl with Hodgkin lymphoma. Journal of assisted reproduction and genetics, 36(8), 1753-1756.
  2. Fair D, Potter SL, Venkatramani (2020). Challenges and solutions to the study of rare childhood tumors. Current opinion in pediatrics, 32(1), 7-12.
  3. Carter-Febres M, Schneller N, Fair D, Solomon D, Perry A, Roy A, Linscott L, Alashari M, Kestle JR, Bruggers C (2020). Adjuvant Maintenance Larotrectinib Therapy in 2 Children With NTRK Fusion-positive High-grade Cancers. Journal of pediatric hematology/oncology, 43(7), e987-e990.
  4. Letourneau J, Fair (2020). Oncofertility in urologic oncology: Fertility preservation for women undergoing cancer treatment. Urologic oncology, 38(1), 14-22.
  5. Warner EL, Vaca Lopez PL, Kepka D, Mann K, Kaddas HK, Fair D, Fluchel M, Knackstedt ED, Pannier ST, Martel L, Kirchhoff A (2020). Influence of provider recommendations to restart vaccines after childhood cancer on caregiver intention to vaccinate. Journal of cancer survivorship, 14(5), 757-767.
  6. Kirchhoff AC, Mann K, Warner EL, Kaddas HK, Fair D, Fluchel M, Knackstedt ED, Kepka (2019). HPV vaccination knowledge, intentions, and practices among caregivers of childhood cancer survivors. Human vaccines & immunotherapeutics, 15(7-8), 1767-1775.
  7. Kaddas HK, Pannier ST, Mann K, Waters AR, Salmon S, Tsukamoto T, Warner EL, Fowler B, Lewis MA, Fair DB, Kirchhoff A (2020). Age-Related Differences in Financial Toxicity and Unmet Resource Needs Among Adolescent and Young Adult Cancer Patients. Journal of adolescent and young adult oncology, 9(1), 105-110.
  8. Warner EL, Fowler B, Pannier ST, Salmon SK, Fair D, Spraker-Perlman H, Yancey J, Randall RL, Kirchhoff A (2018). Patient Navigation Preferences for Adolescent and Young Adult Cancer Services by Distance to Treatment Location. Journal of adolescent and young adult oncology, 7(4), 438-444.
  9. Kaul S, Fair D, Wright J, Kirchhoff A (2016). Dental Care for Survivors of Adolescent and Young Adult Cancer: Special Considerations. Journal of adolescent and young adult oncology, 5(2), 152-8.
  10. Avutu V, Monga V, Mittal N, Saha A, Andolina JR, Bell DE, Fair DB, Flerlage JE, Frediani JN, Heath JL, Kahn JM, Reichek JL, Super L, Terao MA, Freyer DR, Roth M (2021). Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network. JCO oncology practice, OP2100554.
  11. Fair D, Park ER, Nipp RD, Rabin J, Hyland K, Kuhlthau K, Perez GK, Nathan PC, Armstrong GT, Oeffinger KC, Robison LL, Leisenring W, Kirchhoff A (2021). Material, behavioral, and psychological financial hardship among survivors of childhood cancer in the Childhood Cancer Survivor Study. Cancer, 127(17), 3214-3222.
  12. Waters AR, Kepka D, Ramsay JM, Mann K, Vaca Lopez PL, Anderson JS, Ou JY, Kaddas HK, Palmer A, Ray N, Tsukamoto T, Fair DB, Lewis MA, Kirchhoff AC, Warner E (2021). COVID-19 Vaccine Hesitancy Among Adolescent and Young Adult Cancer Survivors. JNCI cancer spectrum, 5(3), pkab049.
  13. Woodruff TK, Ataman-Millhouse L, Acharya KS, Almeida-Santos T, Anazodo A, Anderson RA, Appiah L, Bader J, Becktell K, Brannigan RE, Breech L, Bourlon MT, Bumbuliene ¿, Burns K, Campo-Engelstein L, Campos JR, Centola GM, Chehin MB, Chen D, De Vos M, Duncan FE, El-Damen A, Fair D, Famuyiwa Y, Fechner PY, Fontoura P, Frias O, Gerkowicz SA, Ginsberg J, Gracia CR, Goldman K, Gomez-Lobo V, Hazelrigg B, Hsieh MH, Hoyos LR, Hoyos-Martinez A, Jach R, Jassem J, Javed M, Jayasinghe Y, Jeelani R, Jeruss JS, Kaul-Mahajan N, Keim-Malpass J, Ketterl TG, Khrouf M, Kimelman D, Kusuhara A, Kutteh WH, Laronda MM, Lee JR, Lehmann V, Letourneau JM, McGinnis LK, McMahon E, Meacham LR, Mijangos MFV, Moravek M, Nahata L, Ogweno GM, Orwig KE, Pavone ME, Peccatori FA, Pesce RI, Pulaski H, Quinn G, Quintana R, Quintana T, de Carvalho BR, Ramsey-Goldman R, Reinecke J, Reis FM, Rios J, Rhoton-Vlasak AS, Rodriguez-Wallberg KA, Roeca C, Rotz SJ, Rowell E, Salama M, Saraf AJ, Scarella A, Schafer-Kalkhoff T, Schmidt D, Senapati S, Shah D, Shikanov A, Shnorhavorian M, Skiles JL, Smith JF, Smith K, Sobral F, Stimpert K, Su HI, Sugimoto K, Suzuki N, Thakur M, Victorson D, Viale L, Vitek W, Wallace WH, Wartella EA, Westphal LM, Whiteside S, Wilcox LH, Wyns C, Xiao S, Xu J, Zelinski (2021). A View from the past into our collective future: the oncofertility consortium vision statement. Journal of assisted reproduction and genetics, 38(1), 3-15.
  14. Kirchhoff AC, van Thiel Berghuijs KM, Waters AR, Kaddas HK, Warner EL, Vaca Lopez PL, Perez GK, Ray N, Chevrier A, Allen K, Fair DB, Tsukamoto T, Lewis MA, Haaland B, Park E (2023). Health Insurance Literacy Improvements Among Recently Diagnosed Adolescents and Young Adults With Cancer: Results From a Pilot Randomized Controlled Trial. JCO oncology practice, 20(1), OP2300171.
  15. van Thiel Berghuijs KM, Kaddas HK, Warner EL, Fair DB, Fluchel M, Knackstedt ED, Verma A, Kepka D, Green AL, Smitherman AB, Draper L, Johnson RH, Kirchhoff A (2023). Vaccination practices of pediatric oncologists from eight states. BMC health services research, 23(1), 1215.
  16. Waters AR, Kaddas HK, van Thiel Berghuijs KM, Vaca Lopez PL, Warner EL, Ou JY, Ramsay JM, Palmer A, Ray N, Tsukamoto T, Fair DB, Lewis MA, Linder L, Gill D, Kirchhoff A (2023). COVID-19-Related Employment Disruptions and Increased Financial Burden Among Survivors of Adolescent and Young Adult Cancer. Journal of adolescent and young adult oncology, 12(5), 744-751.
  17. Waters AR, van Thiel Berghuijs KM, Kaddas HK, Vaca Lopez PL, Chevrier A, Ray N, Tsukamoto T, Allen K, Fair DB, Lewis MA, Perez GK, Park ER, Kirchhoff AC, Warner E (2023). Sources of informal financial support among adolescent and young adult cancer survivors: a mixed methods analysis from the HIAYA CHAT study. Supportive care in cancer, 31(3), 159.
  18. Mann K, Waters AR, Park ER, Perez GK, Vaca Lopez PL, Kaddas HK, Warner EL, Ray N, Tsukamoto T, Allen K, Haaland B, Fair DB, Lewis MA, Kirchhoff A (2022). HIAYA CHAT study protocol: a randomized controlled trial of a health insurance education intervention for newly diagnosed adolescent and young adult cancer patients. Trials, 23(1), 682.
  19. Waters AR, Mann K, Warner EL, Vaca Lopez PL, Kaddas HK, Ray N, Tsukamoto T, Fair DB, Lewis MA, Perez GK, Park ER, Kirchhoff A (2022). "I thought there would be more I understood": health insurance literacy among adolescent and young adult cancer survivors. Supportive care in cancer, 30(5), 4457-4464.
  20. Ou JY, Waters AR, Kaddas HK, Warner EL, Lopez PLV, Mann K, Anderson JS, Ray N, Tsukamoto T, Gill D, Linder L, Fair D, Kirchhoff A (2023). Financial burdens during the COVID-19 pandemic are related to disrupted healthcare utilization among survivors of adolescent and young adult cancers. Journal of cancer survivorship, 17(6), 1571-1582.
  21. Vaca Lopez PL, Warner EL, Waters AR, van Thiel Berghuijs KM, Anderson JS, Ray N, Tsukamoto T, Kaddas HK, Fair D, Lewis M, Park ER, Perez GK, Kirchhoff A (2023). Adaptation and Development of a Health Insurance Education Program for Adolescent and Young Adult Cancer Patients. Journal of adolescent and young adult oncology, 12(5), 692-700.
  22. Bhatia S, Pappo AS, Acquazzino M, Allen-Rhoades WA, Barnett M, Borinstein SC, Casey R, Choo S, Chugh R, Dinner S, Ermoian R, Fair D, Federman N, Folbrecht J, Gandhi S, Germann J, Goldsby R, Hayashi R, Huang AY, Huang MS, Jacobs LA, Lee-Miller C, Link MP, Livingston JA, Lustberg M, Malogolowkin M, Oeffinger KC, Pratilas CA, Reed D, Skiles J, von Mehren M, Yeager N, Montgomery S, Hang (2023). Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 21(8), 851-880.
  23. Merjaneh N, Kim H, Escoto H, Metts J, Ray A, Bukowinski A, LeBlanc Z, Fair D, Watanbe M, Alva E, Todd K, Daley J, Hartt D, Cramer SL, Szabo S, Pressey J (2023). Strategies for the Treatment of Infantile Soft Tissue Sarcomas With BCOR Alterations. Journal of pediatric hematology/oncology, 45(6), 315-321.
  24. Lautz TB, Xue W, Luo LY, Fair D, Qumseya A, Gao Z, Dasgupta R, Rodeberg D, Venkatramani (2023). Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Pediatric blood & cancer, 70(7), e30357.
  25. Fair D, Maese L, Chi YY, Li M, Hawkins DS, Venkatramani R, Rudzinski E, Parham D, Teot L, Malkin D, Plon SE, Li H, Sabo A, Lupo PJ, Schiffman J (2023). TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children's Oncology Group report. Pediatric blood & cancer, e30413.
  26. Ou JY, Bennion N, Parker K, Fair D, Hanson HA, Kepka D, Warner EL, Ramsay JM, Kaddas HK, Kirchhoff A (2023). Risk Factors and Trends for HPV-Associated Subsequent Malignant Neoplasms among Adolescent and Young Adult Cancer Survivors. Cancer epidemiology, biomarkers & prevention, 32(5), 625-633.
  27. Kaddas HK, Ramsay JM, Ou JY, Fair D, Kepka D, Kirchhoff A (2023). HPV Vaccination Initiation and Completion Among Pediatric, Adolescent, and Young Adult Cancer Survivors and a Comparison Population Sample Receiving Primary Care. Journal of pediatric hematology/oncology, 45(2), e236-e243.
  28. Cooper LJ, Emery BR, Aston K, Fair D, Rosen MP, Johnstone E, Letourneau J (2022). Fertility preservation practices for female oncofertility differ significantly across the USA: results of a survey of SREI members. Journal of assisted reproduction and genetics, 39(8), 1749-1757.
  29. Schoettler PJ, Smith CC, Nishitani M, Harris AK, Nelson AT, Watson DA, Kamihara J, Mullen EA, Hill DA, Messinger YH, Fair DB, Kumar KA, Dehner LP, Ash S, Chen KS, Schultz KA (2024). Anaplastic sarcoma of the kidney (DICER1-sarcoma of the kidney): A report from the International Pleuropulmonary Blastoma/DICER1 Registry. Pediatric blood & cancer, 71(8), e31090.
  30. Bagatell R, Park JR, Acharya S, Aldrink J, Allison J, Alva E, Arndt C, Benedetti D, Brown E, Cho S, Church A, Davidoff A, Desai AV, DuBois S, Fair D, Farinhas J, Harrison D, Huang F, Iskander P, Kreissman S, Macy M, Na B, Pashankar F, Pendyala P, Pinto N, Polites S, Rabah R, Shimada H, Slatnick L, Sokol E, Twist C, Vo K, Watt T, Wolden S, Zage P, Schonfeld R, Hang (2024). Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 22(6), 413-433.
  31. van Thiel Berghuijs KM, Ray N, Vaca Lopez PL, Waters AR, Tsukamoto T, Kaddas HK, Warner EL, Fair D, Lewis M, Perez GK, Park ER, Kirchhoff A (2025). "I've never personally discussed the cost of anything:" Adolescent and Young Adult Patients with Cancer Experiences and Preferences for Cost-of-Care Conversations. Journal of adolescent and young adult oncology, 14(5), 446-454.
  32. Balis F, Green DM, Armstrong A, Aye J, Benedetti D, Brown B, Brown E, Cook S, Desai A, Dhillon J, Fair D, Geynisman DM, Hiniker S, Horst K, Jasty-Rao R, Just M, Kieran K, Lin C, MacEwan I, Martinez-Agosto J, Mullen E, Murphy ES, Pinto N, Ranalli M, Rhee D, Rokitka D, Walz A, Wickiser J, Yoon J, Zapala M, Montgomery S, Sliker (2025). Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network, 23(8), 319-342.
  33. Alley AW, Cooper LJ, Humphreys MA, Emery BR, Aston KI, Kastenberg ZJ, Luo MX, Hayes KG, Fair D, Mehrhoff C, Letourneau JM, Childress K (2025). Ex vivo oocyte retrieval for fertility preservation in an adolescent patient with recurrent ovarian dysgerminoma: a case report and review of the literature. F&S reports, 6(2), 208-215.
  34. Killela M, Turner CA, Chevrier A, Stefanou M, Vaca Lopez PL, Kaddas HK, van Thiel Berghuijs KM, Warner EL, Perez GK, Waters AR, Fair DB, Nelson RE, Lewis MA, Park ER, Kirchhoff A (2025). CHAT-S Study Protocol: A randomized controlled trial of a health insurance literacy education program for young adult cancer survivors. Preventive oncology & epidemiology, 3(1),
  35. Bhatia S, Pappo AS, Acquazzino M, Allen-Rhoades WA, Barnett M, Borinstein SC, Casey R, Choo S, Chugh R, Dinner S, Ermoian R, Fair D, Federman N, Folbrecht J, Gandhi S, Germann J, Goldsby R, Hayashi R, Huang AY, Huang MS, Jacobs LA, Lee-Miller C, Link MP, Livingston JA, Lustberg M, Malogolowkin M, Oeffinger KC, Pratilas CA, Reed D, Skiles J, von Mehren M, Yeager N, Montgomery S, Hang (2023). Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 21(8), 851-880.
  36. Chevrier A, Vaca Lopez PL, Rogers K, Stefanou M, van Thiel Berghuijs KM, Fair D, Park ER, Kirchhoff AC, Warner E (2025). Adaptation, Feasibility, and Acceptability of a Health Insurance Literacy Intervention for Caregivers of Pediatric Cancer Patients (CHAT-C). Current oncology (Toronto, Ont.), 32(2),

Case Report

  1. Carter-Febres M, Schneller N, Fair D, Solomon D, Perry A, Roy A, Linscott L, Alashari M, Kestle JR, Bruggers C (2021). Adjuvant Maintenance Larotrectinib Therapy in 2 Children With NTRK Fusion-positive High-grade Cancers. Journal of pediatric hematology/oncology, 43(7), e987-e990.

News & Podcasts

Podcasts